
Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to…

Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to…
What they do: AI platform that matches cancer patients to clinical trials and provides concierge enrollment support
Founded: 2014–2015 (company sources list both years)
Headquarters: New York City
Reported patients: Tens of thousands of onboarded cancer patients (reported figures: ~60,000; another source: 160,000)
Total funding (reported): Approximately $23.8M reported across disclosed rounds
Oncology clinical-trial access and patient recruitment
2014
Hospitals and Health Care
2600000
Company reported a $2.6M financing led by Revo Capital
9000000
Company reported a $9M round to scale growth and global expansion
“Includes development finance institutions, venture investors, and philanthropic backers (examples named in disclosures: DEG, IFC, Revo Capital, Charles & Lynn Schusterman Family Philanthropies)”
| Company |
|---|
About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
We're recognized as a leader in health-tech innovation. Massive Bio was featured as #4 in Fast Company's Startup 100 list for Turkey and has raised $24M total funding from impact-driven investors including Revo Capital, the International Finance Corporation, and Cavendish Impact Foundation, validating both our business model and our mission-driven approach.
The Opportunity
We’re hiring a Growth Manager to take ownership of how we acquire and convert users across our platform. This is a hands-on, experiment-driven role for someone who has scaled acquisition funnels in fast-moving environments and wants to apply that skill set to a product with real human impact.
The domain you’ll operate in: Our users are cancer patients and healthcare providers. The conversion funnel is unique; it moves from initial awareness through consent, medical record collection, clinical prescreening, and ultimately enrollment into a trial. You don’t need to come from healthcare to succeed here, but you do need to be excited about learning a complex funnel and finding creative ways to move people through it.
What You’ll Own
Acquisition & Funnel Optimization
Channel Diversification & Experimentation
Growth Strategy & Cross-Functional Collaboration
What Success Looks Like
Who You Are
Required
Nice to Have
Powered by JazzHR
51UDXUITWo
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week